B

BioDelivery Sciences International Inc
F:BD5

Watchlist Manager
BioDelivery Sciences International Inc
F:BD5
Watchlist
Price: 5.05 EUR Market Closed
Market Cap: 521.3m EUR

Operating Margin
BioDelivery Sciences International Inc

22.3%
Current
6%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22.3%
=
Operating Profit
37.1m
/
Revenue
166.7m

Operating Margin Across Competitors

No Stocks Found

BioDelivery Sciences International Inc
Glance View

Market Cap
499.2m EUR
Industry
Pharmaceuticals

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. The company is headquartered in Raleigh, North Carolina and currently employs 200 full-time employees. The company went IPO on 2002-06-25. The firm focuses on delivering therapies for individuals living with serious and debilitating chronic conditions. The Compnay builts a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA), drug-delivery technology to develop and commercialize new applications of therapies aimed at addressing important unmet medical needs. BEMA drug delivery technology consists of a small, bi-layered erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The firm's product candidates includes BELBUCA (buprenorphine buccal film), CIII, for Chronic Pain; Symproic (naldemedine), for Opioid Induced Constipation and ONSOLIS (fentanyl buccal soluble film) for Breakthrough Cancer Pain.

BD5 Intrinsic Value
Not Available
B
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22.3%
=
Operating Profit
37.1m
/
Revenue
166.7m
What is the Operating Margin of BioDelivery Sciences International Inc?

Based on BioDelivery Sciences International Inc's most recent financial statements, the company has Operating Margin of 22.3%.

Back to Top